Enable AccessibilityEnable Accessibility

In the News

What Japan’s Top CEOs Will Take Away From the Pandemic

Named to Institutional Investor’s 2022 All-Japan Executive Team, Christophe Weber shares lessons learned from 2021 and future opportunities for innovation.


Leadership through succession and innovation; Values are the DNA of a company

Christophe Weber speaks with Masahiko Uotani, President and CEO of Japanese cosmetic giant Shiseido, at the 23rd Nikkei Global Management Forum. As Takeda celebrates its 240th anniversary, Shiseido is celebrating its 150th, and both global companies with Japanese roots are embracing change through innovation as they look to the future. The conversation covers  how a company grows strong with innovation

Watch the digest version here

Wall Street Journal: At Takeda, M&A integration on a global fast track

Takeda's finance teams continue to work with the business to drive post-acquisition cost savings and competitive margins, while supporting investment in R&D and new product launches. Learn more here

2021 Scrip Awards: Clinical Advance of the Year

Takeda’s Phase III SOLSTICE trial of maribavir in transplant recipients with CMV infection was named Clinical Advance of the Year at the 2021 Scrip Awards. Learn more here

Fast Company: The climate crisis is a human health crisis.

Recently, during Fast Company’s Innovation Festival, Takeda sponsored a virtual panel with President and CEO Christophe Weber speaking alongside Delta Air Lines’ CEO Ed Bastian and BSR’s President and CEO Aron Cramer. Among the topics discussed were the threat posed by climate change and what it takes to curb it. Learn more here.

Christophe Weber Talks Global Transformation as Takeda is Named to Fortune’s Global 500 List

As Takeda makes Fortune’s Global 500 for the second consecutive year, Takeda’s President and CEO Christophe Weber speaks with Fortune’s Alan Murray about our global transformation, innovative R&D pipeline and focus on purpose-led sustainability. Watch here.

For Japan’s Top CEOs, It’s Change or Die

Named to Institutional Investor’s 2021 All-Japan Executive Team as a top-scoring chief executive, Christophe Weber shares insight into Takeda’s innovation strategy.


First non-Japanese CEO of Takeda has set out 2 objectives: to be an R&D-driven firm and to build global scale

Christophe Weber, named by Insider as one of 10 leaders transforming healthcare in Asia, reflects on Takeda’s transformation to a global, R&D-driven biopharmaceutical company.



The Asahi Shimbun Globe Series

In life, there are great opportunities as well as great challenges and risks. With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.


Takeda CEO: Japanese startups should go global from Day One

In the final installment of this interview series, Christophe Weber talks about the challenges of globalization with his message for the Japanese business community.



Respect for local culture vital for survival as CEO in Japan

Christophe Weber on Takeda’s corporate governance system and the importance of being open and transparent to build trust.


Takeda CEO Would Have Scrapped Shire Deal If Leaked

Christophe Weber talks about how confidentiality was maintained during Shire negotiations and the challenges of large-scale integration.


Takeda CEO Tackles Japan’s Seniority-Based System

President and CEO Christophe Weber explains how Takeda is developing “Global Talent” with the ability to perform on an international business stage.


Takeda President Says Firm’s Reform Was “Stressful” but “Essential”

Christophe Weber explains how he has reformed the company since he took office in 2014.


Takeda President Explains Why Pharma Firms Need M&A

Following the largest-ever merger and acquisition deal by a Japanese company, CEO & President Christophe Weber explains the importance of M&As to Pharma’s future.


What makes a company truly global?

Christophe Weber reflects on Takeda's history and values, and the importance of diversity in the workplace.


Tragedies changed my life:

CEO Christophe Weber talks about how his past shaped who he is today.


JN2820 Scrip Awards 2019 Winner Logos 371x255_16.jpg

Takeda Named Pharmaceutical Company of the Year at 2019 Scrip Awards

Takeda was named Pharma Company of the Year at the 2019 Scrip Awards. The award winner is chosen by Scrip’s senior editorial team to honor outstanding achievements and strategic advancements over the past year.

Financial Times: Universal Health Coverage One Trained Professional at a Time

Despite technological advances, the delivery of high-quality health care remains a human-centered activity. Takeda is supporting NGO Seed Global Health to use the power of people to tackle the health challenges of sub-Saharan Africa.



EuroBiz: Total Transformation - Takeda readies itself for the future

CEO Christophe Weber speaks openly to Eurobiz Japan on the ups and downs of Takeda's `total transformation`, his strategic approach to R&D and of the exciting promise of what's to come.